For instance, in Quebec, weight-related issues are frequently seen as the individual's own burden, with treatment primarily emphasizing behavioral adjustments instead of relying on medical treatments. In Alberta, Lau explained that it involves a blend of approaches, tailored to each individual's needs.
'Individuals who become overweight or obese,' he noted, 'have their neural pathways altered so that they persistently desire additional sustenance, especially items high in sugar or fats. Consequently, modifying these pathways proves exceedingly difficult without supporting long-term adoption of nutritious dietary patterns. This is precisely where GLP-1 drugs, among other therapies, prove invaluable, as they aid in reducing both the quantity and type of consumed foods.'
